Clinical Trial: Use of Clomiphene Citrate as an Inhibitor of Ovulation in an Oocyte Cryopreservation Cycle

Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: OBSERVATIONAL




Official Title: Use of Clomiphene Citrate as an Inhibitor of Ovulation in an Oocyte Cryopreservation Cycle

Brief Summary: In vitro fertilization (IVF) has helped countless couples conceive where they otherwise were unable, but does come at a significant cost.
A large portion of that cost is in the medications that allow for controlled ovarian hyperstimulation.
One aspect of treatment is in ovulation inhibition to allow for supraphysiologic recruitment of oocytes prior to natural ovulation.
Historically, GnRH agonist and antagonists have been used.
However, these are subcutaneous injections and can be costly.
Clomiphene citrate is a selective estrogen receptor modulator that acts as an estrogen antagonist in the hypothalamus and pituitary and is an inexpensive oral agent.
It may be used as an inhibitor of ovulation in IVF in theory but this has never been attempted to the best of our knowledge.